Sovenyr Get early access

Signal2026-08-09

PubMed

Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

Part of

Emerging Cancer Biomarker Techniques

Open primary source See the whole picture

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.